Fundraising Fox
Restor3D
Durham, US · Founded 2017 · Delaware corporation · 292 employees on LinkedIn · 2 known investors
Find your way into Restor3D
127 people in our graph share verified history with the Restor3D team — schools, employers, funds. One of them is your warm intro.
Stewart Gollmerunlockedknows Greg Anglum · together at Overture Networks (overlapped)
×2knows the team · via Restor3D
×2knows the team · via Bioventus
×7knows the team · via Vanderbilt University Owen Graduate School of Management
restor3d designs and manufactures patient-specific 3D-printed orthopaedic implants for musculoskeletal reconstruction, using osseointegrative biomaterials, AI-driven design, and digital health tools. Its products serve surgeons and patients across foot and ankle, knee, and hip procedures, with support for pre-surgical planning and personalized instrumentation.
Founders & leadership
Restor3D was founded in 2017 by Cambre Kelly, Kenneth Gall, and Kurt Jacobus.
KG
Kenneth GallCo-founder
AM
Andrew MillerExecutive
MF
Michael FillionExecutive
GA
Greg AnglumChief Financial Officer2022–2026He has over 20 years of experience in finance and strategy, including involvement with public offerings, acquisitions, debt financings, and exits across multiple industries. He holds an MBA and is a CPA and Chartered Global Management Accountant.
Board
SE
Stuart E. HustonBoard director
BN
Brian NeiswenderBoard director
AS
Andrew SummersBoard director
MP
Michael PorterBoard director
DK
Douglas KohrsBoard director
Investors · 2
Hatteras Venture PartnersreportedResearch Triangle · $500K – $4M
How we know: the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$239.2M disclosed across 10 rounds · 2017–2025
▶$84.8MraisedAug 2025 · 133 investors · Other Health CareRule 506(b)
▶$84.8MraisedAug 2025 · 133 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Kurt JacobusExecutive Officer, Director
- Andrew SummersDirector
- Andrew MillerExecutive Officer
- Greg AnglumExecutive Officer
- Kenneth GallExecutive Officer
- Douglas KohrsDirector
- Erich WolffDirector
- Cambre KellyExecutive Officer
- Brian NeiswenderDirector
- Stuart E. HustonDirector
- Michael PorterDirector
- Offering amount
- $94.8M
- Amount sold
- $84.8M
- First sale
- Aug 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$28.4MraisedApr 2025 · 127 investors · Other Health CareRule 506(b)
▶$28.4MraisedApr 2025 · 127 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Cambre KellyExecutive Officer
- Kenneth GallExecutive Officer, Director
- Andrew MillerExecutive Officer
- Stuart E. HustonDirector
- Michael FillionExecutive Officer
- Kurt JacobusExecutive Officer, Director
- Brian NeiswenderDirector
- Greg AnglumExecutive Officer
- Andrew SummersDirector
- Douglas KohrsDirector
- Michael PorterDirector
- Offering amount
- $40M
- Amount sold
- $28.4M
- Minimum investment
- $25K
- First sale
- Jan 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$55MraisedJun 2024 · 150 investors · Other Health CareRule 506(b)
▶$55MraisedJun 2024 · 150 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Andrew SummersDirector
- Douglas KohrsDirector
- Andrew MillerExecutive Officer
- Stuart HustonDirector
- Brian NeiswenderDirector
- Ken GallExecutive Officer, Director
- Kurt JacobusExecutive Officer, Director
- Greg AnglumExecutive Officer
- Cambre KellyExecutive Officer
- Michael PorterDirector
- Offering amount
- $55M
- Amount sold
- $55M
- Minimum investment
- $25K
- First sale
- Jan 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$17MraisedSep 2023 · 98 investors · Other Health CareRule 506(b)
▶$17MraisedSep 2023 · 98 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Andrew MillerExecutive Officer, Director
- James StubbsDirector
- Brian GarveyDirector
- Brian NeiswenderDirector
- Tarek ShoebDirector
- Steven JoungDirector
- Kurt JacobusExecutive Officer, Director
- Greg AnglumExecutive Officer
- Cambre KellyExecutive Officer
- William RhodaDirector
- Lawrence BoydExecutive Officer
- Ken GallExecutive Officer, Director
- Offering amount
- $17M
- Amount sold
- $17M
- Minimum investment
- $25K
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$12MraisedMay 2023 · 96 investors · Other Health CareRule 506(b)
▶$12MraisedMay 2023 · 96 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- James StubbsDirector
- Andrew MillerExecutive Officer, Director
- Brian GarveyDirector
- Lawrence BoydExecutive Officer
- Brian NeiswenderDirector
- Greg AnglumExecutive Officer
- Tarek ShoebDirector
- Kurt JacobusExecutive Officer, Director
- Cambre KellyExecutive Officer
- Steven JoungDirector
- Bill RhodaDirector
- Ken GallExecutive Officer, Director
- Offering amount
- $12M
- Amount sold
- $12M
- Minimum investment
- $25K
- First sale
- May 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$23MraisedApr 2022 · 202 investors · OtherRule 506(b)
▶$23MraisedApr 2022 · 202 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Brian GarveyDirector
- William RhodaDirector
- Brian NeiswenderDirector
- Steve JoungDirector
- Kurt JacobusExecutive Officer, Director
- James StubbsDirector
- Ken GallExecutive Officer, Director
- Andrew MillerExecutive Officer, Director
- Offering amount
- $23M
- Amount sold
- $23M
- Proceeds to insiders
- $925K
- First sale
- Mar 2022
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$13MraisedMay 2021 · 101 investors · OtherRule 506(b)
▶$13MraisedMay 2021 · 101 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Andrew MillerExecutive Officer, Director, Promoter
- Steve JoungDirector
- Kurt JacobusDirector
- Ken GallDirector
- James StubbsDirector
- Brian NeiswenderDirector
- Offering amount
- $13M
- Amount sold
- $13M
- First sale
- May 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$4.9MraisedFeb 2020 · 48 investors · OtherRule 506(b)
▶$4.9MraisedFeb 2020 · 48 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Andrew MillerExecutive Officer, Director, Promoter
- Kurt JacobusDirector
- James StubbsDirector
- Steve JoungDirector
- Brian NeiswenderDirector
- Ken GallDirector
- Offering amount
- $5M
- Amount sold
- $4.9M
- First sale
- Jan 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 7
by search overlap
Practo1818 shared keywordsPracto operates an online healthcare platform offering a directory of verified doctors, appointment booking at hospitals and clinics, online consultations across 20+ specialities, subscription health plans, diagnostic test collection, and medicine delivery. It also provides practice management and hospital information management software for clinics and hospitals.
BirdEye1041 shared keywordsBirdeye offers an AI-powered platform with multi-agent "AI Coworkers" that handle marketing, operations, and customer experience tasks such as search optimization, review generation, listings management, social posting, and front-desk coordination. It serves multi-location businesses, providing a unified view of customers, locations, and interactions.
Sharecare914 shared keywordsSharecare provides AI-powered health navigation for employers and health plans, connecting employees' health questions to their available benefits and appropriate care options. The platform surfaces relevant wellness programs, chronic condition management, and advocacy services within employees' moment of need.
Read the Press Release866 shared keywordsStryker is a medical technology company that develops and manufactures products across areas such as orthopaedics, surgical equipment, neurotechnology, and spine care for hospitals and healthcare providers. It operates globally across the Americas, Europe, Asia-Pacific, and the Middle East.
Doximity711 shared keywordsDoximity is the largest verified network of healthcare professionals in the U.S., connecting physicians, PAs, NPs, pharmacists, and medical students across specialties and care settings. The platform provides mobile-first tools for clinical communication, collaboration, and workflow optimization.
Nextdoor (NYSE: 2021)672 shared keywordsNeighborhood social network; IPO 2021
Zocdoc650 shared keywordsZocdoc runs an online marketplace where US patients find in-network doctors and dentists and book in-person or telehealth appointments.
Companies competing with Restor3D for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Restor3D do?
- restor3d designs and manufactures patient-specific 3D-printed orthopaedic implants for musculoskeletal reconstruction, using osseointegrative biomaterials, AI-driven design, and digital health tools. Its products serve surgeons and patients across foot and ankle, knee, and hip procedures, with support for pre-surgical planning and personalized instrumentation.
- Who founded Restor3D?
- Restor3D was founded by Cambre Kelly, Kenneth Gall, Kurt Jacobus in 2017.
- Who are Restor3D's investors?
- Restor3D's investors include Duke Capital Partners, Hatteras Venture Partners.
- How much funding has Restor3D raised?
- Restor3D has disclosed $239.2M raised across 10 rounds.
- Where is Restor3D headquartered?
- Restor3D is headquartered in Durham, US.